1-9 of 9
YOUNG HOON KIM
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Meeting Abstracts

656-P: Antifibrotic Potential of a Novel Long-Acting Glucagon/GIP/GLP-1 Triple Agonist (HM15211) in Preclinical Models of Fibrosis

JUNG KUK KIM, JONG SUK LEE, SEON MYEONG LEE, HYUNJOO KWON, JAEHYUK CHOI, EUNJIN PARK, SUNGMIN BAE, DAEJIN KIM, YOUNG HOON KIM, IN YOUNG CHOI
Journal: Diabetes
Diabetes 2021;70(Supplement_1):656-P
DOI: https://doi.org/10.2337/db21-656-P
Published: 01 June 2021
View article
Meeting Abstracts

658-P: Sustained Glucagon Effect on Cardiovascular Renal and Metabolic Disorders Mediated by a Long-Acting Glucagon Analog, HM15136, in Animal Disease Models

JONG SUK LEE, SEON MYEONG LEE, JUNG KUK KIM, EUNJIN PARK, JONGSOO LEE, DAEJIN KIM, YOUNG HOON KIM, IN YOUNG CHOI
Journal: Diabetes
Diabetes 2021;70(Supplement_1):658-P
DOI: https://doi.org/10.2337/db21-658-P
Published: 01 June 2021
View article
Meeting Abstracts

108-LB: Sustained Glucagon Effect on Blood Glucose and Improvements of Insulin Resistance Mediated by a Novel Long-Acting Glucagon Analog, HM15136, in Animal Models

JAEHYUK CHOI, SEON MYEONG LEE, JUNG KUK KIM, JONGSOO LEE, YOUNG HOON KIM, IN YOUNG CHOI
Journal: Diabetes
Diabetes 2019;68(Supplement_1):108-LB
DOI: https://doi.org/10.2337/db19-108-LB
Published: 01 June 2019
View article
Meeting Abstracts

1011-P: Therapeutic Potential of Novel Combination of a Long-Acting Glucagon Analog (HM15136) and Antidiabetic Drugs for the Treatment of Obesity

YOUNG JIN PARK, JONG SUK LEE, JUNG KUK KIM, DAEJIN KIM, YOUNG HOON KIM, YOUNG CHOI IN
Journal: Diabetes
Diabetes 2019;68(Supplement_1):1011-P
DOI: https://doi.org/10.2337/db19-1011-P
Published: 01 June 2019
View article
Meeting Abstracts

990-P: Therapeutic Effect of a Novel Long-Acting GLP-1/GIP/Glucagon Triple Agonist (HM15211) in a NASH and Fibrosis Animal Model

JUNG KUK KIM, JONG SUK LEE, DAEJIN KIM, EUNJIN PARK, YOUNG HOON KIM, IN YOUNG CHOI
Journal: Diabetes
Diabetes 2019;68(Supplement_1):990-P
DOI: https://doi.org/10.2337/db19-990-P
Published: 01 June 2019
View article
Meeting Abstracts

1810-P: Effect of HM15211, a Novel Long-Acting GLP-1/GIP/Glucagon Triple Agonist in the Neurodegenerative Disease Models

KIM WONKI, JEONG A. KIM, SANG HYUN LEE, SUNGMIN BAE, IN YOUNG CHOI, YOUNG HOON KIM
Journal: Diabetes
Diabetes 2019;68(Supplement_1):1810-P
DOI: https://doi.org/10.2337/db19-1810-P
Published: 01 June 2019
View article
Meeting Abstracts

Neuroprotective Effects of HM15211, a Novel Long-Acting GLP-1/GIP/Glucagon Triple Agonist in the Neurodegenerative Disease Models

JEONG A. KIM, SANGDON LEE, SANG HYUN LEE, SUNG YOUB JUNG, YOUNG HOON KIM, IN YOUNG CHOI, SUN JIN KIM
Journal: Diabetes
Diabetes 2018;67(Supplement_1):1107-P
DOI: https://doi.org/10.2337/db18-1107-P
Published: 01 July 2018
View article
Meeting Abstracts

Bone Protective Effect of a Novel Long-Acting GLP-1/GIP/Glucagon Triple Agonist (HM15211) in an Animal Model

SANGDON LEE, YU-YON KIM, JONG SUK LEE, SANG HYUN LEE, YOUNG HOON KIM, IN YOUNG CHOI, SUN JIN KIM
Journal: Diabetes
Diabetes 2018;67(Supplement_1):1105-P
DOI: https://doi.org/10.2337/db18-1105-P
Published: 01 July 2018
View article
Meeting Abstracts

Effect of a Novel Long-Acting GLP-1/GIP/Glucagon Triple Agonist (HM15211) in a NASH and Fibrosis Animal Model

IN YOUNG CHOI, JUNG KUK KIM, JONG SUK LEE, EUNJIN PARK, YOUNG HOON KIM, SUNG YOUB JUNG, SUN JIN KIM
Journal: Diabetes
Diabetes 2018;67(Supplement_1):1106-P
DOI: https://doi.org/10.2337/db18-1106-P
Published: 01 July 2018
View article